The management of acute bone loss in severe catabolism due to burn injury

Hormone Research

Volumn 48, Issue SUPPL. 5, 1997, Pages 83-87

  Klein, G L ^a,b   Wolf, S E ^a,b   Goodman, W G ^c   Phillips, W A ^a,b   Herndon, D N ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bone density; Bone formation; Bone resorption; Burns; Cytokines; Glucocorticoids; Growth hormone; Immobilization

Indexed keywords

GLUCOCORTICOID; HUMAN GROWTH HORMONE; MAGNESIUM; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

BONE ATROPHY; BONE DENSITY; BONE MARROW SUPPRESSION; BONE MASS; BONE METABOLISM; BONE MINERAL; BURN; CATABOLISM; CONFERENCE PAPER; HUMAN; HYPERCALCIURIA; IMMOBILIZATION; MAGNESIUM DEFICIENCY; OSSIFICATION; OSTEOLYSIS; PRIORITY JOURNAL;

EID: 0030727589     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000191334     Document Type: Conference Paper

References (30)

1. Schaffler MB, Li XJ, Jee WSS, Ho SWW, Stern PJ: Skeletal tissue responses to thermal injury: An experimental study. Bone 1988;9:397-406.
2. Klein GL, Herndon DN, Rutan TC, Sherrard DJ, Coburn JW, Langman CB, Thomas ML, Haddad JG Jr, Cooper CW, Miller NL, Alfrey AC: Bone disease in burn patients. J Bone Miner Res 1993;8:337-345.
3. Klein GL, Herndon DN, Goodman WG, Langman CB, Phillips WA, Dickson IR, Eastell RE, Naylor KE, Maloney NA, Desai M, Benjamin D, Alfrey AC: Histomorphometric and biochemical characterization of bone following acute severe burns in children. Bone 1995;17: 455-460.
4. Klein GL, Herndon DN, Langman CB, Rutan TC, Young WE, Pembleton G, Nusynowitz M, Bamett JL, Broemeling LD, Sailer DE, McCauley RL: Long-term reduction in bone mass after severe burn injury in children. J Pediatr 1995; 126:252-256.
5. Muller MJ, Gilpin DA, Herndon DN: Modulation of wound healing and the postburn response; in Herndon DN (ed): Total Burn Care. London, Saunders, 1996, pp 223-236.
6. Lephart ED, Baxter CR, Parker CR Jr: Effect of burn trauma on adrenal and testicular hormone production. J Clin Endocrinol Metab 1987;64:842-848.
7. Canalis E: Regulation of bone remodelling; in Favus MJ (ed): Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Philadelphia, Lippincott-Raven, 1996, 3rd ed, pp 29-34.
8. Harries RHC, Phillips LG: Hematologic and acute phase response; in Herndon DN (ed): Total Burn Care. London, Saunders, 1996, pp 293-301.
9. Yang KH, Stewart AF: Miscellaneous causes of hypercalcemia; in Favus MJ (ed): Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Philadelphia, Lippincott-Raven, 1996, 3rd ed, pp 213-217.
10. Arnaud SB, Sherrard DJ, Maloney N, Whalen RT, Fung P: Effects of 1-week head-down tilt bed rest on bone formation and the calcium endocrine system. Aviat Space Environ Med 1992;63:14-20.
11. LeBlanc AD, Schneider VS, Evans HJ, Engelbretson DA, Krebs JM: Bone mineral loss and recovery after 17 weeks of bed rest. J Bone Miner Res 1990;5:843-850.
12. Klein GL, Kikuchi Y, Sherrard DJ, Simmons DJ, Biondo N, Traber DL: Burn-associated bone disease in sheep: Roles of immobilization and endogenous corticosteroids. J Burn Care Rehabil 1996;17:518-521.
13. Stapleton FB, Roy S, Noe HN, Jerkins G: Hypercalciuria in children with hematuria. N Engl J Med 1984;310:1345-1348.
14. Klein GL, Nicolai M, Langman CB, Cuneo BF, Sailer DE, Herndon DN: Dysregulation of calcium homeostasis following severe burn injury in children: Possible role of magnesium depletion. J Pediatr, in press.
15. Eyre DR: Biochemical markers of bone turnover; in Favus MJ (ed): Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Philadelphia, Lippincott-Raven, 1996, 3rd ed, pp 114-118.
16. Gore DC, Honeycutt D, Jahoor F, Wolfe RR, Herndon DN: Effect of exogenous growth hormone on whole-body and isolated-limb protein kinetics in burned patients. Arch Surg 1991; 126:38-43.
17. Gilpin DA, Barrow RE, Rutan RL, Broemeling L, Herndon DN: Recombinant human growth hormone accelerates wound healing in children with large cutaneous burns. Ann Surg 1994; 220:19-24.
18. Herndon DN, Barrow RE, Kunkel KR, Broemeling L, Rutan RL: Effect of recombinant human growth hormone on donor site healing in severely burned children. Ann Surg 1990; 212:424-431.
19. Fleming RYD, Rutan RL, Jahoor F, Barrow RE, Wolfe RR, Herndon DN: Effect of recombinant human growth hormone on catabolic hormones and free fatty acids following thermal injury. J Trauma 1992;32:698-703.
20. Herndon DN, Hawkins HK, Nguyen TT, Pierre E, Cox R, Barrow RE. Characterization of growth hormone enhanced donor site healing in patients with large cutaneous burns. Ann Surg 1995;221:649-656.
21. Kanzaki S, Hosoda K, Moriwake T, Tanaka H, Kubo T, Inoue M, Higuchi J, Seino Y: Serum propeptide and intact molecular osteocalcin in normal children and children with growth hormone (GH) deficiency: A potential marker of bone growth and response to GH therapy. J Clin Endocrinol Metab 1992;75:1104-1109.
22. Kubo T, Tanaka H, Inoue M, Kanzaki S, Seino Y: Serum levels of carboxyterminal propeptide of type I procollagen and pyridinoline cross-linked telopeptide of type I collagen in normal children and children with growth hormone (GH) deficiency during GH therapy. Bone 1995;17:397-401.
23. Saggese G, Baroncelli GI, Bertelloni S, Clin-quanta L, Nero GD: Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency. J Pediatr 1993;122:37-45.
24. Sanchez CP, Goodman WG, Brandli D, Goldenhersch M, Murray C, Carlton E, Hahn T, Salusky IB: Skeletal response to recombinant human growth hormone (rHGH) in children treated with long-term corticosteroids. J Bone Miner Res 1995;10:2-6.
25. Rutan RL, Herndon DN: Growth delay in postburn pediatric patients. Arch Surg 1990; 125:392-395.
26. Zhang RW, Simmons DJ, Crowther RS, Mohan S, Baylink DJ: Contribution of marrow stromal cells to the regulation of osteoblast proliferation in rats: Evidence for involvement of insulin-like growth factors. Bone Miner 1991; 13:201-215.
27. Johansson AG, Forslund A, Hambraeus L, Blum WF, Ljunghall S: Growth hormone-dependent insulin-like growth factor binding protein is a major determinant of bone mineral density in healthy men. J Bone Miner Res 1994;9:915-923.
28. Kleerekoper M, Avioli LV: Evaluation and treatment of postmenopausal osteoporosis; in Favus MJ (ed): Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Philadelphia, Lippincott-Raven, 1996, 3rd ed, pp 264-271.
29. Finkelstein JS, Klibanski A, Schaeffer EH, Hornstein MD, Schiff I, Neer RM: Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency. N Engl J Med 1994;331:1618-1623.
30. Pak CYC, Zerwekh JE, Antich PP, Bell NH, Singer FR: Slow-release sodium fluoride in osteoporosis. J Bone Miner Res 1996;11:561-564.